Blog Archives

Plaquenil/hydroxychloroquine may have more extraglandular benefits for Sjogren’s Syndrome patients

Hydroxychloroquine (generic Plaquenil) is often prescribed off-label by doctors for Sjogren’s Syndrome patients despite the fact that it has never been approved by governing agencies like the FDA. I myself have taken hydroxychloroquine for several years. Studies have generally found that hydroxychloroquine

Posted in Research, Treatment, Uncategorized Tagged with: ,

Sjogren’s Syndrome diagnosis, seronegativity, and the CFS/ME/fibromyalgia dumping ground

I’ve seen a lot of discussion in online forums asking if someone with negative tests actually has SS. One one hand, no one wants to be misdiagnosed. If, for example, a patient’s symptoms are actually caused by hypothyroidism, they will

Posted in Diagnosis, Treatment Tagged with: , ,

Plaquenil toxicity and lowering dosage

Plaquenil (generic name hydroxychloroquine) is one of the few medications that is regularly prescribed for Sjogren’s Syndrome, despite the fact that it has not been approved for SS by the FDA, so any use is off-label. While clinical trials for it’s

Posted in Research, Treatment Tagged with:
WordPress Appliance - Powered by TurnKey Linux